Should bisphosphonates be standard therapy for bone pain?

Supportive Care in Cancer

Volumn 5, Issue 3, 1997, Pages 200-204

  Paterson, A H G ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Bisphosphonates; Bone metastases; Bone pain; Hypercalcaemia

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; PAMIDRONIC ACID;

ARTICLE; BONE METASTASIS; BONE PAIN; BREAST CANCER; CANCER PAIN; HUMAN; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MYELOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANALGESICS, NON-NARCOTIC; BONE NEOPLASMS; CLODRONIC ACID; DIPHOSPHONATES; FEMALE; HUMANS; HYPERCALCEMIA; MALE; PAIN;

EID: 0030944615     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050060     Document Type: Article

References (21)

1. Belch AR, Bergsagel DE, Wilson K, O'Reilly S, Wilson J, Sutton D, Pater J, Johnston D, Zee B (1991) Effect of daily etidronate on the osteolysis of multiple myeloma. J Clin Oncol 9:1397-1402
2. Berenson JR, Lichtenstein A, Porter L, et al (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma N Engl J Med 334.8:488-493
3. Clemens MR, Fessele K, Heim ME (1993) Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications. Ann Hematol 66:141-146
4. Delmas PD (1991) The use of clodronate in multiple myeloma. Bone 12 [Suppl 1]:S31-S34
5. Ernst DS, MacDonald N, Paterson AHG, Jensen J, Brasher P, Bruera E (1992) A double-blind, crossover trial of intravenous clodronate in metastatic bone pain. J Pain Symptom Manage 7:4-11
6. Ernst DS, Brasher P, Hagen N, Paterson AHG, MacDonald RN, Bruera E (1994) Controlled trial of intravenous clodronate in patients with metastatic bone disease and pain (abstract 1478). Proc ASCO 13:431
7. Hortobagyi GN, Porter L, Blayney D, Theriault RL, Lipton A, Gluck S, Wheeler H, Allan S, Simeone J, Seaman J, Knight R, Heffernan M, Reitsma D (1996) Reduction of skeletal related complications in breast cancer patients with osteolytic bone metastases receiving chemotherapy (CT), by monthly pamidronate sodium (PAM) (AREDIAS) infusion (abstract 99). Proc ASCO 15:108
8. Kanis JA, Percival RC, Yates AJP, Urwin GH, Hamdy NAT (1986) Effects of diphosphonates in hypercalcaemia due to neoplasia. Lancet I:615-616
9. Kanis JA, Ashley S, McCloskey E, Paterson AHG, Powles TJ (1996) The use of oral clodronate in patients with recurrent breast cancer in the absence of skeletal metastases: a double blind placebo controlled trial. Bone (in press)
10. Lahtinen R, Leekso M, Palva L, Virkkunen P, Elomaa L, for the Finnish Leukaemia Group (1992) Randomized, placebo-controlled multi-centre trial of clodronate in multiple myeloma. Lancet 340:1049-1052
11. Mundy GR (1987) Bone resorption and turnover in health and disease. Bone 8 [Suppl 1]:S9-S16
12. Mundy GR (1988) Hypercalcemia of malignancy revisited. J Clin Invest 82:1-6
13. O'Rourke N, McCloskey EV, Vasikaran S, Eyres K, Fern D, Kanis JA (1993) Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate. Br J Cancer 67:560-563
14. Orr FW, Varani J, Gondetz MD, Ward PA, Mundy GR (1979) Chemotactic responses of tumor cells to products of resorbing bone. Science 203:176-179
15. Paget S (1889) The distribution of secondary growths in cancer of the breast (classical article). Lancet I:571-573
16. Paterson AHG (1987) Bone metastases in breast cancer, prostate cancer and myeloma. Bone 8 [Suppl 1]:S17-S22
17. Paterson AHG, Ernst DS, Powles TJ, Ashley S, McCloskey EV, Kanis JA (1991) Treatment of skeletal disease in breast cancer with clodronate. Bone 12 [Suppl 1]:S25-S30
18. Paterson AHG, Powles TJ, Kanis JA, McCloskey EV, Hanson J, Ashley S (1993) Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 11:59-65
19. Percival RC, Urwin GH, Beneton MNC, Williams JL, Kanis JA (1985) Early effects of diphosphonates on mineralization (abstract). Calcif Tissue Int 38:S37
20. Ryzon B, Martodam RR, Troxell M, Benson A, Paterson A, Shepard K, Hicks R (1985) Intravenous etidronate in the management of malignant hypercalcemia. Arch Intern Med 145:449-452
21. Van Holten-Verzantvoort AT, Bijvoet OLM, Mermans J, et al (1987) Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet II:983-985